Immediate-release/extended-release amantadine (OS320) to treat Parkinson's disease with levodopa-induced dyskinesia: Analysis of the randomized, controlled ALLAY-LID studies. - Rascol, Olivier; Tönges, Lars; deVries, Tina; Jaros, Mark; Quartel, Adrian; Jacobs, David; ALLAY-LID I and ALLAY-LID II study groups (Parkinsonism & Related Disorders, 2022)